Zurich Cantonal Bank
KITE

Zurich Cantonal Bank’s Kite Pharma, Inc. KITE Stock Holding History

Zurich Cantonal Bank’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,592
Closed -$2.08M – 2613
2017
Q3 		$2.08M Buy
11,592
+9,608
+484% +$1.34M 0.02% 623
2017
Q2 		$206K Sell
1,984
-9,500
-83% -$775K ﹤0.01% 989
2017
Q1 		$901K Sell
11,484
-278
-2% -$17.2K 0.01% 801
2016
Q4 		$527K Sell
11,762
-94,723
-89% -$4.65M 0.01% 855
2016
Q3 		$5.95M Buy
106,485
+871
+0.8% +$48.5K 0.06% 347
2016
Q2 		$5.28M Buy
105,614
+3,140
+3% +$154K 0.07% 309
2016
Q1 		$4.71M Sell
102,474
-7,193
-7% -$348K 0.06% 333
2015
Q4 		$6.76M Buy
109,667
+5,662
+5% +$399K 0.09% 229
2015
Q3 		$5.79M Buy
104,005
+95,420
+1,111% +$6M 0.08% 227
2015
Q2 		$523K Buy
8,585
+2,872
+50% +$164K 0.01% 837
2015
Q1 		$330K Buy
+5,713
New +$383K ﹤0.01% 881

Zurich Cantonal Bank's KITE Position: Q4 2017 in Review

Zurich Cantonal Bank sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 11,592 shares — an estimated $2.08M sold.

Zurich Cantonal Bank first reported a position in KITE in Q1 2015 and held it in 11 quarters. The position peaked at $6.76M in Q4 2015. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Zurich Cantonal Bank reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Zurich Cantonal Bank sold 11,592 Kite Pharma, Inc. shares in Q4 2017, an estimated $2.08M.
  • Zurich Cantonal Bank first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 11 quarters.
  • Zurich Cantonal Bank's Kite Pharma, Inc. position peaked at $6.76M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Zurich Cantonal Bank's 13F filing for Q4 2017, filed 31 Jan 2018.